United States News Todas as matérias

Escalade (NASDAQ:ESCA) announced the acquisition of the assets of ASL Solutions, a Ste. Marie, Illinois-based manufacturer of insulated dog and cat houses and accessories, expanding its U.S. manufacturing operations into the pet products market.

Soluna Holdings (NASDAQ:SLNH) announced that a subsidiary entered into an agreement with Bitdeer Technologies Group (NASDAQ:BTDR) to deploy approximately 28 MW of Bitcoin mining equipment at Soluna’s Project Kati 1 data center in South Texas.

Senstar Technologies (NASDAQ:SNT) announced second-quarter 2026 revenue of $10.4 million, up 8% from $9.7 million a year earlier, while higher operating expenses reduced operating income and net profit.

Tuniu (NASDAQ:TOUR) today revealed second-quarter 2026 net revenues of RMB138.9 million, up 3% year over year, driven by higher packaged tour revenue, while increased costs reduced profitability.

BMO Financial Group (NYSE:BMO) reported third-quarter 2026 net income of $1.75 billion, down 25% year over year, while adjusted net income increased 19% to $2.859 billion after excluding a goodwill-related charge.

Vipshop (NYSE:VIPS) reported second-quarter 2026 net revenues of RMB24.7 billion, down from RMB25.8 billion in the prior-year period, while net income attributable to shareholders increased to RMB4.3 billion due to a one-time investment gain.

Brent crude prices fell to their lowest level since August 19, while U.S. West Texas Intermediate (WTI) reached their weakest level since August 17 as concerns over immediate military escalation between the United States and Iran eased.

EHang (NASDAQ:EH) reported second-quarter 2026 revenue of RMB77.9 million, increasing 203.5% from the previous quarter as deliveries reached 36 eVTOL aircraft, while revenue declined 31.3% year over year.

Johnson & Johnson (NYSE:JNJ) received U.S. Food and Drug Administration approval for IMAAVY (nipocalimab-aahu) as the first treatment specifically approved for warm autoimmune hemolytic anemia (wAIHA) in adults and pediatric patients aged 12 years and older.

Global Net Lease (NYSE:GNL) closed its acquisition of Modiv Industrial to integrate a $535 million portfolio of industrial net-lease properties across the United States.

GreenTree Hospitality Group (NYSE:GHG) reported second-quarter 2026 revenue of RMB235.1 million (US$34.7 million), down 18.7% year over year, as lower hotel and restaurant revenue affected overall results.

KKR (NYSE:KKR) agreed to acquire the Japanese beauty and lifestyle brand platform Ci FLAVORS from its existing corporate shareholders.

Woodside Energy Group (NYSE:WDS) reported first-half 2026 operating revenue of $7.446 billion, up 13% year over year, with net profit after tax of $1.672 billion and continued progress across major energy projects.

Molecular Partners (NASDAQ:MOLN) reported first-half 2026 results and clinical progress across its oncology pipeline, including MP0712, a DLL3-targeting Radio-DARPin program for small cell lung cancer that advanced into the next trial cohort.

Cadeler (NYSE:CDLR) reported first-half 2026 revenue of EUR 408 million, an increase of EUR 220 million from the adjusted prior-year period, as the offshore wind installation company expanded fleet activity and contracted days.

Rhythm Pharmaceuticals (NASDAQ:RYTM) received Japanese marketing authorization for its IMCIVREE therapy, targeting a company-estimated 5,000 to 8,000 obesity patients.

NVIDIA (NASDAQ:NVDA) placed its Groq 3 LPX AI inference accelerator into full production to process agentic workloads at 3,400 tokens per second.

Boeing (NYSE:BA) engineers and technical workers rejected a four-year contract offer from the company, with members of the Society of Professional Engineering Employees in Aerospace authorizing a potential strike after the contract expires in October.

Tesla (NASDAQ:TSLA) announced plans to unveil the production version of its Cybercab robotaxi at a launch event in Austin, Texas, on September 3.

REGENXBIO (NASDAQ:RGNX) reported that the U.S. Food and Drug Administration placed a clinical hold on its investigational MPS II gene therapy RGX-121 following spine MRI findings in five participants in the CAMPSIITE study.

Monte Rosa Therapeutics (NASDAQ:GLUE) announced that the first patient has been dosed in MODeFIRe-1, a Phase 2 trial evaluating investigational molecular glue degrader MRT-2359 with apalutamide in patients with AR mutation-positive metastatic castration-resistant prostate cancer.

VERAXA Biotech (NASDAQ:VRXA) and Secarna Pharmaceuticals announced a research milestone in their collaboration to develop antibody-oligonucleotide conjugates for autoimmune and chronic immune diseases.

Philip Morris International (NYSE:PM) announced that its non-U.S. affiliates entered a contract manufacturing arrangement with Philip Morris USA, an operating company of Altria (NYSE:MO), for combustible cigarettes.

TwinStrand Biosciences announced that the U.S. District Court for the District of Delaware entered final judgment in favor of TwinStrand and the University of Washington in their patent infringement case against Guardant Health (NASDAQ:GH), awarding more than $245.2 million in damages, royalties, and interest.